Inactive Instrument

Winsan (Chengdu) Medical Science and Technology Co., Ltd.

Equities

600767

CNE000000N89

IT Services & Consulting

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Winsan Shanghai Medical to Be Delisted From Shanghai Bourse MT
Winsan Medical Science And Technology Co., Ltd. canceled the agreement to acquire a 52% stake in Shenzhen Good Feel Dental Group Co., Ltd from GoodFeel Enterprises, GoodFeel Management, Zhang Huitu, Qin Youbing, Peng CI
Winsan Medical Science And Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Winsan Medical Science and Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Winsan Shanghai Medical Science CFO Resigns MT
Winsan Medical Science and Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Winsan Medical Science and Technology Co., Ltd. intends to acquire 52% interest in Shenzhen Good Feel Dental Group Co., Ltd from GoodFeel Enterprises, GoodFeel Management, Zhang Huitu, Qin Youbing, Peng for approximately CNY 156 million. CI
Winsan Medical Science and Technology Co., Ltd.(SHSE:600767) dropped from Shanghai Stock Exchange Composite Index CI
Winsan Medical Science and Technology Co., Ltd.(SHSE:600767) dropped from Shanghai Stock Exchange A Share Index CI
Winsan Medical Science and Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Winsan Medical Science and Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Winsan Medical Science and Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Winsan Medical Science and Technology Co., Ltd.(SHSE:600767) added to Shanghai Stock Exchange A Share Index CI
Winsan Medical Science and Technology Co., Ltd.(SHSE:600767) added to Shanghai Stock Exchange Composite Index CI
Winsan Chengdu Medical Science and Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Winsan Chengdu Medical Science and Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Winsan Chengdu Medical Science and Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Huayun Xin Investment Partnership (Limited Partnership) signed an equity transfer agreement to acquire 24.34% stake in Winsan Medical Science and Technology Co., Ltd. from Sichuan Lanrun Asset Management Co., Ltd. for CNY 600 million. CI
Winsan Medical Science and Technology Co., Ltd. completed the acquisition of 30% stake in Shenzhen Xinrun Hongjin Industrial Co., Ltd. from Xiao Yun. CI
Winsan Medical Science and Technology Co., Ltd. intends to acquire remaining 30% stake in Shenzhen Xinrun Hongjin Industrial Co., Ltd. from Xiao Yun for CNY 3.6 million. CI
Winsan Chengdu Medical Science and Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Winsan Chengdu Medical Science and Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Winsan Medical Science and Technology Co., Ltd. Elects Wang Xi as Director CI
Winsan Medical Science and Technology Co., Ltd. cancelled the acquisition of remaining 16% stake in Jingde Honglin Health Industry Development Co., Ltd. from Wang Longfa. CI
Winsan Medical Science and Technology Co., Ltd. has Changed its Name to Winsan Medical Science and Technology Co., Ltd CI
Chart Winsan (Chengdu) Medical Science and Technology Co., Ltd.
More charts
WINSAN (SHANGHAI) MEDICAL SCIENCE AND TECHNOLIGY CO.LTD, formerly WINSAN (SHANGHAI) INDUSTRIAL CORPORATION LTD., is a China-based company principally engaged in technology development, technical consultation, technical service, medical equipment operation in the public health and regional medical information field, as well as technology development of computer hardware and software in the medical field. The Company is also engaged in the leasing and sales of houses, as well as sales of medical devices. The Company mainly operates its businesses in domestic market.
More about the company